Corcept Therapeutics Inc

Corcept Therapeutics Inc Stock

47.17P/E
€6.27BMarket capitalisation
US$1.33Earnings
—Dividend yield

Current price

—
1D
1W
1M
3M
6M
1Y
3Y
Max

Company description

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

Corcept Therapeutics Inc is registered in the following country: United States of America (Exchange: USNASD).

Key metrics

Key metrics and master data for the Corcept Therapeutics Inc stock.

Market capitalisation
€6.27B
P/E
47.17
P/B
8.14
P/S
7.78
P/CF
37.87
Issued shares 109M Units

Return

Here you can see the performance of the Corcept Therapeutics Inc stock.

PeriodPerfor­mance
1 Week-14.09 %
1 Month-42.89 %
3 Months-44.14 %
6 Months+22.41 %
1 Year-12.22 %
YTD-15.41 %

Dividends

With an (expected) annual dividend of —, the current stock price results in a dividend yield of —.

Dividend type—
(Expected) annual dividend —
Dividend yield —

Splits

The table shows the splits of the Corcept Therapeutics Inc share.

DateRatio
No data available.

Which ETF contains the Corcept Therapeutics Inc stock?

The Corcept Therapeutics Inc stock is contained in a total of 0 ETFs with at least 1%. You can find a list of these ETFs in the following table. With —, Corcept Therapeutics Inc has the largest weight in .

Name
Weighting
Region
Country
TER
Replication
Volume (£m)

Frequently asked questions

Here you can find all answers to your questions about the Corcept Therapeutics Inc stock.

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.